Figure 7. Absolute tendon fibril diameter distribution during 2 weeks of immobilisation and after 6 weeks of re-training in young males (n= 20) with either recombinant human growth hormone (rhGH) (n= 10) or placebo (n= 10).

A, fibril diameter distribution of the GH and placebo groups at baseline. B, fibril diameter distribution of the GH and placebo groups after 2 weeks of immobilisation (Post immob). C, fibril diameter distribution of the GH and placebo groups after 6 weeks of training. No time effect or group interactions were seen within time points. Data are means ± SEM.